United Kingdom· GB-APID-34543211000001104
Zinplava 1g/40ml concentrate for solution for infusion vials
A bezlotoxumab product containing bezlotoxumab, registered in United Kingdom by Merck Sharp & Dohme (UK) Ltd. The same ATC class is registered in 9 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Bezlotoxumab is registered in 9 of 19 countries.
Countries holding a registration under ATC J06BC03 (bezlotoxumab), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Bezlotoxumab · ATC J06BC03
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Bezlotoxumab
- Manufacturer
- Merck Sharp & Dohme (UK) Ltd
- Country
- United Kingdom (GB)
- ATC code
- J06BC03
- ATC class
- Bezlotoxumab
- Defined daily dose
- 0.7 g, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5013945301908
- gtin00191778009040
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bezlotoxumab in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumZinplava 25 mg/mlMerck Sharp & Dohme
- CzechiaZINPLAVAMerck Sharp & Dohme B.V., Haarlem
- SpainZINPLAVA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONMerck Sharp & Dohme B.V.
- FinlandZINPLAVAMerck Sharp & Dohme B.V.
- FranceZINPLAVA 25 mg/mL, solution à diluer pour perfusionMERCK SHARP & DOHME (PAYS-BAS)
- IrelandZINPLAVA 25 mg/mL concentrate for solution for infusionMerck Sharp & Dohme BV
- IcelandZinplavaMerck Sharp & Dohme B.V.*
- NetherlandsZINPLAVA 25 mg/ml, concentraat voor oplossing voor infusieMerck Sharp & Dohme B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zinplava
- Liechtenstein · Zinplava
- Norway · Zinplava
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1a89401a-9fce-4017-acb8-0d93eef04b3e GET /v1/drugs/1a89401a-9fce-4017-acb8-0d93eef04b3e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "34543211000001104",
"desc": "Zinplava 1g/40ml concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd)",
"form": "Solution for infusion",
"vpid": "34543011000001109",
"source": "dmd",
"vtm_id": "774853004",
"strength": "25 mg",
"substance": "Bezlotoxumab",
"ingredient": "Bezlotoxumab",
"supplier_code": "39306911000001106"
}See everything about bezlotoxumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.